KCT0000176招募中未知
A Randomized, Open Label, Multiple-Dose, Cross-over Clinical Study to Investigate Pharmacokinetics and Drug-Drug Interaction between Rosuvastatin and CS-866 in Healthy Male Volunteers
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 50(Year)（—）
- 性别
- Male
入选标准
- •1.Healthy adult male volunteers aged 20 to 50 years
- •2.A subject who provided written informed consent to participate in this study and cooperative with regard to compliance with study related constraints
排除标准
- •1.A subject who had any allergic history to any drug.
- •2.A subject with sign or symptoms or previously diagnosed disease of liver, kidney, neurology, respiratory, endocrinology, hematology, cardiovascular, genitourinary, psychology, ophthalmic, dermatology and gastrointestinal function or other significant diseases
- •3.History or suspicion of current drug abuse
- •4.A subject who had received treatment with below listed drug within specified period prior to the first dose of study medication
- •?Within 1 month: drug known CYP inducer or inhibitor
- •?Within 2 weeks: Prescribed or herbal medicine
- •?Within 1 weeks: OTC medicine
- •?Within 2 days: Consumption of caffeine
- •5.A subject who had participated in any other clinical study within the last 2 weeks
- •6.A subject from whom over 400mL of blood was sampled(whole blood donation) within last 2 weeks or plasma/platelet donation within 1 month.
研究者
相似试验
已完成
不适用
Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic AlopeciaDiseases of the skin and subcutaneous tissueKCT0001989Dong-A ST14
尚未招募
1 期
Phase-I bridging study of TRC041266 Powder in healthy human subjects.CTRI/2020/04/024708Dr Sanjay Sharma
尚未招募
1 期
A Multiple-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Trimetazidine Dihydrochloride 80 mg Prolonged-release Capsules and Reference Product in Healthy Thai Volunteers under Fed ConditionsHealthy subjectsBioequivalence Trimetazidine Dihydrochloride 80 mgTCTR20240529007Bio-innova Co., Ltd.34
尚未招募
1 期
A Multiple-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiq) in Healthy Thai Volunteers under Fasting ConditionsHealthy subjectsBioequivalence Desvenlafaxine 50 mgTCTR20240322003Bio-innova Co., Ltd.30
已完成
不适用
Clinical study to evaluate pharmacokinetic drug-drug interaction and safety between nebivolol and rosuvastatiDiseases of the circulatory systemKCT0001794Elyson Pharmaceutical44